<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>药春秋 | wechat-feeds</title><link>http://MzI0MDM2NTA4NQ.favicon.privacyhide.com/favicon.ico</link><description>医药行业一致性评价工作在如火如荼的进行中，作为行业的一份子，愿本愚公之念，出蝼蚁 之力，献寸光之策。</description><managingEditor> (hellodword)</managingEditor><pubDate>Sun, 14 Mar 2021 23:18:02 +0800</pubDate><image><url>http://MzI0MDM2NTA4NQ.favicon.privacyhide.com/favicon.ico</url><title>药春秋 | wechat-feeds</title><link>http://MzI0MDM2NTA4NQ.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>全球最大的多肽类供应商之一，和它的王牌品种！</title><link>https://mp.weixin.qq.com/s/6mrG-dk95Gz8q318WuO_Jg</link><description></description><content:encoded><![CDATA[全球最大的多肽类供应商之一，和它的王牌品种！]]></content:encoded><pubDate>Sun, 14 Mar 2021 22:28:23 +0800</pubDate></item><item><title>引进日本产品，它能帮你！</title><link>https://mp.weixin.qq.com/s/kzLM-LvzNdnKe8Odk2fFtg</link><description></description><content:encoded><![CDATA[引进日本产品，它能帮你！]]></content:encoded><pubDate>Sun, 14 Mar 2021 22:28:23 +0800</pubDate></item><item><title>佰药云—产品推广服务</title><link>https://mp.weixin.qq.com/s/YbUsosi_tzUxWyRiI81dFA</link><description></description><content:encoded><![CDATA[佰药云—产品推广服务]]></content:encoded><pubDate>Sun, 14 Mar 2021 22:28:23 +0800</pubDate></item><item><title>当原料药与制剂，不得不分手时……</title><link>https://mp.weixin.qq.com/s/3WdxdGiR-voFTzS883m-CA</link><description></description><content:encoded><![CDATA[当原料药与制剂，不得不分手时……]]></content:encoded><pubDate>Fri, 12 Mar 2021 18:39:19 +0800</pubDate></item><item><title>【项目合作】三款进口大健康产品，寻国内经销商</title><link>https://mp.weixin.qq.com/s/e25ALYBNDWdF-WuNK6ctnQ</link><description></description><content:encoded><![CDATA[【项目合作】三款进口大健康产品，寻国内经销商]]></content:encoded><pubDate>Fri, 12 Mar 2021 18:39:19 +0800</pubDate></item><item><title>3品种首家过评，涉及一品红、石药、华润等大药企！</title><link>https://mp.weixin.qq.com/s/zKOvrCeWU5Kk6NfRYz2k9A</link><description></description><content:encoded><![CDATA[3品种首家过评，涉及一品红、石药、华润等大药企！]]></content:encoded><pubDate>Fri, 12 Mar 2021 21:38:30 +0800</pubDate></item><item><title>刚刚！第四十一批参比目录公示，13个品种审议不通过...</title><link>https://mp.weixin.qq.com/s/sKkhxrsI2RonW1k1EDIpXA</link><description></description><content:encoded><![CDATA[刚刚！第四十一批参比目录公示，13个品种审议不通过...]]></content:encoded><pubDate>Fri, 12 Mar 2021 21:38:30 +0800</pubDate></item><item><title>注意！这6个药品被撤网</title><link>https://mp.weixin.qq.com/s/-5TVp7aPueOQQLW3YE4GVA</link><description></description><content:encoded><![CDATA[注意！这6个药品被撤网]]></content:encoded><pubDate>Fri, 12 Mar 2021 21:38:30 +0800</pubDate></item><item><title>集采后产物，大批药品联动降价</title><link>https://mp.weixin.qq.com/s/9yRR6Clf-kWaegvmcr66mg</link><description></description><content:encoded><![CDATA[集采后产物，大批药品联动降价]]></content:encoded><pubDate>Fri, 12 Mar 2021 21:38:30 +0800</pubDate></item><item><title>佰药云—调研报告服务</title><link>https://mp.weixin.qq.com/s/pYGWy9Yp7Exkeey4Bw804w</link><description></description><content:encoded><![CDATA[佰药云—调研报告服务]]></content:encoded><pubDate>Fri, 12 Mar 2021 21:38:30 +0800</pubDate></item><item><title>全球肿瘤畅销药Top 10，合计大卖700亿美元！</title><link>https://mp.weixin.qq.com/s/4h4yyhYF69orFXOIa7A__A</link><description></description><content:encoded><![CDATA[全球肿瘤畅销药Top 10，合计大卖700亿美元！]]></content:encoded><pubDate>Thu, 11 Mar 2021 21:45:21 +0800</pubDate></item><item><title>省际集采如期推进，注射剂占比达八成...</title><link>https://mp.weixin.qq.com/s/hMEnNPWpgX8SB9YG0tgXrA</link><description></description><content:encoded><![CDATA[省际集采如期推进，注射剂占比达八成...]]></content:encoded><pubDate>Thu, 11 Mar 2021 21:45:21 +0800</pubDate></item><item><title>佰药云-审计服务</title><link>https://mp.weixin.qq.com/s/BcdLVfeBL7j4h5zH9TqEaQ</link><description></description><content:encoded><![CDATA[佰药云-审计服务]]></content:encoded><pubDate>Thu, 11 Mar 2021 21:45:21 +0800</pubDate></item><item><title>2022年6月大限，医保乙类增补药全部清出！</title><link>https://mp.weixin.qq.com/s/NJDR1_Ky9RFcsB8uovRaUg</link><description></description><content:encoded><![CDATA[2022年6月大限，医保乙类增补药全部清出！]]></content:encoded><pubDate>Thu, 11 Mar 2021 21:45:21 +0800</pubDate></item><item><title>一致性评价新动态，注射剂收获颇丰！</title><link>https://mp.weixin.qq.com/s/IDhD5VryOLPOwIA5oUWeBg</link><description></description><content:encoded><![CDATA[一致性评价新动态，注射剂收获颇丰！]]></content:encoded><pubDate>Wed, 10 Mar 2021 21:43:40 +0800</pubDate></item><item><title>【项目合作】三款日本产品，寻国内授权经销商</title><link>https://mp.weixin.qq.com/s/YJIfiJBsw0VouwfDbGBsIA</link><description></description><content:encoded><![CDATA[【项目合作】三款日本产品，寻国内授权经销商]]></content:encoded><pubDate>Wed, 10 Mar 2021 21:43:40 +0800</pubDate></item><item><title>降价！37个临床常用药在列</title><link>https://mp.weixin.qq.com/s/4jvaCPL2abwc9ha2dSrgiQ</link><description></description><content:encoded><![CDATA[降价！37个临床常用药在列]]></content:encoded><pubDate>Wed, 10 Mar 2021 21:43:40 +0800</pubDate></item><item><title>关注丨全国医疗最新数据，两批国采平均降价53%...</title><link>https://mp.weixin.qq.com/s/wittzqI3bCciwVLGeAOwPg</link><description></description><content:encoded><![CDATA[关注丨全国医疗最新数据，两批国采平均降价53%...]]></content:encoded><pubDate>Wed, 10 Mar 2021 21:43:40 +0800</pubDate></item><item><title>佰药云-清关代理服务</title><link>https://mp.weixin.qq.com/s/y98QgeN-YxzJqM7PjZqTaA</link><description></description><content:encoded><![CDATA[佰药云-清关代理服务]]></content:encoded><pubDate>Wed, 10 Mar 2021 21:43:40 +0800</pubDate></item><item><title>图说|一致性评价，你的溶出曲线跑了-原料晶型</title><link>https://mp.weixin.qq.com/s/WPrGlu0t3bA7D33pZXtc_w</link><description></description><content:encoded><![CDATA[图说|一致性评价，你的溶出曲线跑了-原料晶型]]></content:encoded><pubDate>Tue, 09 Mar 2021 21:37:15 +0800</pubDate></item></channel></rss>